Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
SciSparc Ltd. - Ordinary Shares
(NQ:
SPRC
)
0.2143
-0.0060 (-2.72%)
Streaming Delayed Price
Updated: 12:56 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about SciSparc Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
September 30, 2024
SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon.
Via
Benzinga
Exposures
Product Safety
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
September 17, 2024
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
September 17, 2024
Via
Benzinga
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 29, 2024
Via
Benzinga
Why Is SciSparc (SPRC) Stock Up 94% Today?
August 15, 2024
SciSparc stock is up on Thursday with heavy trading of SPRC shares after it provided an update on its merger with AutoMax.
Via
InvestorPlace
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via
Benzinga
Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients
August 20, 2024
SciSparc Ltd. (NASDAQ: SPRC) announced on Tuesday that the first five patients have been enrolled and dosed into its ongoing clinical trial in children suffering from autism spectrum disorder (ASD) at...
Via
Benzinga
Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy
August 19, 2024
SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties.
Via
Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 19, 2024
Via
Benzinga
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
August 15, 2024
Via
Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
August 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 15, 2024
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!
Via
InvestorPlace
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
August 15, 2024
Via
Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Mizuho Just Issued a Warning on Palantir (PLTR) Stock
July 16, 2024
Palantir Technologies stock is down on Tuesday after shares of PLTR were hit with a downgrade from Mizuho analysts this morning.
Via
InvestorPlace
Why Is SciSparc (SPRC) Stock Up 25% Today?
July 16, 2024
SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 16, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
Via
InvestorPlace
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 11, 2024
Via
Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
April 16, 2024
Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into...
Via
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Via
Benzinga
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
April 11, 2024
SciSparc to acquire AutoMax Motors, forming a new entity with SciSparc owning over 50%. SciSparc's core operations to continue.
Via
Benzinga
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant...
Via
Benzinga
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
March 12, 2024
Via
Benzinga
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
March 08, 2024
The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Via
Benzinga
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
February 27, 2024
Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
February 20, 2024
SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.